Global Whole Genome Amplification Market is forecasted to reach over USD 6.5 Million by 2034

Future Market Insights projects substantial growth in the global whole genome amplification market, driven by the technique’s increasing importance in forensic studies and genetic disorder research. According to their estimates, the market is expected to reach over USD 6.5 million by 2034, up from USD 2.9 million in 2024, with a CAGR of 8.1% from 2024 to 2034.

The growing demand for whole genome amplification is fueled by the expanding need for genetic data collection to map every gene in the human genome. In particular, whole-cell genome amplification has gained significant attention, supported by rising awareness and global initiatives aimed at promoting this technology. These trends are anticipated to create lucrative opportunities for market players during the forecast period.

Key Growth Drivers:

• Government support for genomic research and technology.
• An increase in the number of genome studies being conducted worldwide.
• A significant reduction in the cost of whole-genome sequencing.

The expanding applications of genomics across diverse fields—such as molecular diagnostics, oncology, and personalized medicine—are further driving demand for WGA technology. As genomics research continues to influence medical advancements, WGA is emerging as an essential tool for identifying genetic mutations, particularly in cancer research, and for analyzing small DNA samples in forensic science.

A Vital Tool for Research:

Whole genome amplification involves the enzymatic replication of small amounts of genomic DNA, usually measured in nanograms, to produce a larger quantity of DNA suitable for detailed study. This process is indispensable in cancer research, where it helps identify mutations linked to tumor development, and in forensic science, where it assists in analyzing small DNA samples from crime scenes.

“The ability to increase the quantity of DNA available for research has made WGA a critical tool across various scientific fields. It allows scientists to study genes in finer detail, particularly when working with conserved specimens,” said a Future Market Insights analyst.

Future Outlook:

As molecular diagnostics and genomics research continue to evolve, the adoption of whole genome amplification will play a pivotal role in advancing personalized medicine and other scientific disciplines. With increasing awareness of the benefits of WGA, combined with government backing, the market is poised for robust growth over the next decade. This growth reflects the potential of WGA to unlock new insights into genetic research and provide solutions for critical challenges in medical and forensic fields.

Growing Market Interest: Explore Comprehensive Insights and Trends with Our Detailed Report!

Key Takeaways from the Whole Genome Amplification Market Report:

• The whole genome amplification industry demands for single cell WGA kit with revenue share of 1% in 2024.
• In 2024, the whole genome amplification market is estimated to utilize by the 1% for agriculture and veterinary applications.
• The whole genome amplification industry in the United States is anticipated to see a CAGR of 4% from 2024 to 2034.
• The Chinese whole genome amplification sector is projected to showcase a CAGR of 9% through 2034.
• The whole genome amplification market in India is anticipated to display a CAGR of 7% by 2034.

Competitive Analysis of the Whole Genome Amplification Sector:

Many considerations indicate that the whole genome amplification industry will likely increase significantly in the near future. An important feature of this dynamic expansion is the rise of alliances and partnerships across operating companies, which intensifies competitiveness in the market.

The expansion of product portfolios and strategic activities, including collaborations, licensing, and mergers and acquisitions, are expected to fuel demand for whole genome amplification. The market has continued to develop because of such significant mergers and acquisitions, which have helped the market’s steady growth.

Recent Developments in the Whole Genome Amplification Sector:

• BioSkryb Genomics introduced ResolveDNA Whole Genome and ResolveOME Whole Genome and Transcriptome Single-Cell Core Kits in March 2024. These kits use primary template-directed amplification to provide high-resolution single-cell DNA insights.

Leading Whole Genome Amplification Brands:

• GE Healthcare
• Sygnis AG
• Illumina, Inc.
• Merck KGaA
• Thermo Fisher Scientific Inc.
• Eurofins Scientific
• Agilent Technologies, Inc.
• Oxford Nanopore Technologies
• F. Hoffmann-La Roche Ltd
• Bio-Rad Laboratories, Inc.

Key Segments of Market Report:

By Product Type:

As per product type, the industry has been segmented into single-cell WGA kits, complete WGA kits, WGA re-amplification kits, WGA and chip DNA kits, and others.

By Application:

The segment is branched into applications for drug discovery and development, disease diagnosis, agriculture, veterinary research, forensics, and others.

By End User:

Pharma and biotech companies, hospitals and clinics, contract research organizations, research and academic institutes, and others mainly utilize the sector.

By Region:

Industry analysis has been carried out in key countries of North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East and Africa.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube